Early ART-initiation and longer ART duration reduces HIV-1 proviral DNA levels in children from the CHER trial. (2021)

First Author: Payne H

Attributed to: Blood borne viruses funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s12981-021-00389-1

PubMed Identifier: 34587974

Publication URI: http://europepmc.org/abstract/MED/34587974

Type: Journal Article/Review

Volume: 18

Parent Publication: AIDS research and therapy

Issue: 1

ISSN: 1742-6405